Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
February 28, 2004
Metastatic malignant melanoma
J B Meric, O Rixe, D Khayat
Bulletin Du Cancer
|
April 27, 2010
[New therapeutics strategies in renal cell carcinoma]
J-B Meric, B Billemont, O Rixe
Abdominal Imaging
|
February 20, 2003
Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography
M F Bellin, L Lebleu, J B Meric
Current Medical Research and Opinion
|
November 26, 2005
Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy
J Bloch, O Rixe, J B Meric, et al.
Bulletin Du Cancer
|
May 13, 2009
[Angiogenesis: a new therapeutic target of thoracic and laryngopharyngeal carcinoma]
L Taillade, I Alexandre, B Billemont, et al.
British Journal of Cancer
|
October 9, 2008
Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
B Billemont, J Medioni, L Taillade, et al.
Bulletin Du Cancer
|
February 15, 2001
[Zd 1839 "Iressa"]
J B Meric, S Faivre, C Monnerat, et al.
Current Oncology (Toronto, Ont.)
|
December 15, 2010
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial
H Assi, G Missenard, P Terrier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2008
[Neoadjuvant therapy for renal cancer]
F Thibault, O Rixe, J-B Meric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2011
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)
T C Gauler, B Besse, A Mauguen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Drugs of Today (Barcelona, Spain : 1998)
|
February 28, 2004
Metastatic malignant melanoma
J B Meric, O Rixe, D Khayat
Bulletin Du Cancer
|
April 27, 2010
[New therapeutics strategies in renal cell carcinoma]
J-B Meric, B Billemont, O Rixe
Abdominal Imaging
|
February 20, 2003
Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography
M F Bellin, L Lebleu, J B Meric
Current Medical Research and Opinion
|
November 26, 2005
Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy
J Bloch, O Rixe, J B Meric, et al.
Bulletin Du Cancer
|
May 13, 2009
[Angiogenesis: a new therapeutic target of thoracic and laryngopharyngeal carcinoma]
L Taillade, I Alexandre, B Billemont, et al.
British Journal of Cancer
|
October 9, 2008
Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib
B Billemont, J Medioni, L Taillade, et al.
Bulletin Du Cancer
|
February 15, 2001
[Zd 1839 "Iressa"]
J B Meric, S Faivre, C Monnerat, et al.
Current Oncology (Toronto, Ont.)
|
December 15, 2010
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial
H Assi, G Missenard, P Terrier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2008
[Neoadjuvant therapy for renal cancer]
F Thibault, O Rixe, J-B Meric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2011
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)
T C Gauler, B Besse, A Mauguen, et al.
Page
of 1